Growing community of inventors

Daejeon, South Korea

Yejin Jang

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Yejin JangYoung Il Yeom (1 patent)Yejin JangKyungjin Kim (1 patent)Yejin JangKyung Chan Park (1 patent)Yejin JangUk-Il Kim (1 patent)Yejin JangHyang-Sook Yoo (1 patent)Yejin JangHyung Tae Bang (1 patent)Yejin JangJung Ju Lee (1 patent)Yejin JangJong Young Choi (1 patent)Yejin JangSuk-Jin Yang (1 patent)Yejin JangIn Young Park (1 patent)Yejin JangJin Soo Shin (1 patent)Yejin JangMeehyein Kim (1 patent)Yejin JangYun Young Go (1 patent)Yejin JangHwajung Nam (1 patent)Yejin JangBo Hwa Sohn (1 patent)Yejin JangJihye Yoon (1 patent)Yejin JangYejin Jang (2 patents)Young Il YeomYoung Il Yeom (10 patents)Kyungjin KimKyungjin Kim (9 patents)Kyung Chan ParkKyung Chan Park (4 patents)Uk-Il KimUk-Il Kim (3 patents)Hyang-Sook YooHyang-Sook Yoo (3 patents)Hyung Tae BangHyung Tae Bang (3 patents)Jung Ju LeeJung Ju Lee (2 patents)Jong Young ChoiJong Young Choi (2 patents)Suk-Jin YangSuk-Jin Yang (2 patents)In Young ParkIn Young Park (2 patents)Jin Soo ShinJin Soo Shin (1 patent)Meehyein KimMeehyein Kim (1 patent)Yun Young GoYun Young Go (1 patent)Hwajung NamHwajung Nam (1 patent)Bo Hwa SohnBo Hwa Sohn (1 patent)Jihye YoonJihye Yoon (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Korea Research Institute of Bioscience and Biotechnology (1 from 321 patents)

2. St Pharm Co., Ltd. (1 from 19 patents)


2 patents:

1. 11655268 - Nucleoside or nucleotide derivatives, and uses thereof

2. 8703419 - Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single CpG site in TTP promoter and treatment of cancers by regulating its epigenetic status

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…